Novobiocin

CHEMBL36506 Phase 4 Disetujui Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
612.6 g/mol
LogP
3.3
Phase
4

An aminocoumarin antibiotic derived from Streptomyces that inhibits bacterial DNA gyrase, used to treat infections caused by Staphylococcus aureus and certain other gram-positive bacteria. It was also investigated in combination regimens for multidrug-resistant infections.

Berat Molekul

612,6000 g/mol

LogP

3,30

TPSA

196,00 Ų

Lipinski RO5

Gagal

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Struktur 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O)[C@H](Oc2ccc3c(O)c(NC(=O)c4ccc(O)c(CC=C(C)C)c4)c(=O)oc3c2C)OC1(C)C

InChI

InChI=1S/C31H36N2O11/c1-14(2)7-8-16-13-17(9-11-19(16)34)27(37)33-21-22(35)18-10-12-20(15(3)24(18)42-28(21)38)41-29-23(36)25(43-30(32)39)26(40-6)31(4,5)44-29/h7,9-13,23,25-26,29,34-36H,8H2,1-6H3,(H2,32,39)(H,33,37)/t23-,25+,26-,29-/m1/s1

Molecular Formula

C31H36N2O11

HBD / HBA

5 / 11

Ikatan yang Dapat Dirotasi

9

Atom Berat

44

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Pertanyaan yang Sering Diajukan

An aminocoumarin antibiotic derived from Streptomyces that inhibits bacterial DNA gyrase, used to treat infections caused by Staphylococcus aureus and certain other gram-positive bacteria. It was also investigated in combination regimens for multidrug-resistant infections.

Yes, Novobiocin is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL36506. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 54675769. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Penyangkalan Medis

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.